Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

1.

Antibodies reacting with Simian Virus 40 capsid protein mimotopes in serum samples from patients affected by uveal melanoma.

Bononi I, Perri P, Begnardi A, Martini A, Mazzoni E, Bosi S, Pietrobon S, Sebastiani A, Tognon M, Martini F.

J Hematol Oncol. 2014 Apr 29;7(1):38. doi: 10.1186/1756-8722-7-38.

PMID:
24886631
[PubMed - in process]
Free PMC Article
2.

Simultaneous inhibition of the HGF/MET and Erk1/2 pathways affect uveal melanoma cell growth and migration.

Chattopadhyay C, Grimm EA, Woodman SE.

PLoS One. 2014 Feb 13;9(2):e83957. doi: 10.1371/journal.pone.0083957. eCollection 2014.

PMID:
24551032
[PubMed - in process]
Free PMC Article
3.

Ocular tumors: Triumphs, challenges and controversies.

Eagle RC Jr.

Saudi J Ophthalmol. 2013 Jul;27(3):129-32. doi: 10.1016/j.sjopt.2013.06.002. No abstract available.

PMID:
24227975
[PubMed]
Free PMC Article
4.

Ocular melanoma: an overview of the current status.

Jovanovic P, Mihajlovic M, Djordjevic-Jocic J, Vlajkovic S, Cekic S, Stefanovic V.

Int J Clin Exp Pathol. 2013 Jun 15;6(7):1230-44. Print 2013. Review.

PMID:
23826405
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Lack of GNAQ and GNA11 Germ-Line Mutations in Familial Melanoma Pedigrees with Uveal Melanoma or Blue Nevi.

Hawkes JE, Campbell J, Garvin D, Cannon-Albright L, Cassidy P, Leachman SA.

Front Oncol. 2013 Jun 28;3:160. doi: 10.3389/fonc.2013.00160. Print 2013.

PMID:
23825798
[PubMed]
Free PMC Article
6.

Patient survival in uveal melanoma is not affected by oncogenic mutations in GNAQ and GNA11.

Koopmans AE, Vaarwater J, Paridaens D, Naus NC, Kilic E, de Klein A; Rotterdam Ocular Melanoma Study group.

Br J Cancer. 2013 Jul 23;109(2):493-6. doi: 10.1038/bjc.2013.299. Epub 2013 Jun 18.

PMID:
23778528
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

BRAF, GNAQ, and GNA11 mutations and copy number in pediatric low-grade glioma.

Laviv Y, Toledano H, Michowiz S, Dratviman-Storobinsky O, Turm Y, Fichman-Horn S, Kagnovski E, Goldenberg-Cohen N.

FEBS Open Bio. 2012 Jun 1;2:129-34. doi: 10.1016/j.fob.2012.05.004. Print 2012.

PMID:
23650591
[PubMed]
Free PMC Article
8.

Ultradeep sequencing detects GNAQ and GNA11 mutations in cell-free DNA from plasma of patients with uveal melanoma.

Metz CH, Scheulen M, Bornfeld N, Lohmann D, Zeschnigk M.

Cancer Med. 2013 Apr;2(2):208-15. doi: 10.1002/cam4.61. Epub 2013 Feb 14.

PMID:
23634288
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Melanoma patients in a phase I clinic: molecular aberrations, targeted therapy and outcomes.

Henary H, Hong DS, Falchook GS, Tsimberidou A, George GC, Wen S, Wheler J, Fu S, Naing A, Piha-Paul S, Janku F, Kim KB, Hwu P, Kurzrock R.

Ann Oncol. 2013 Aug;24(8):2158-65. doi: 10.1093/annonc/mdt115. Epub 2013 Apr 10.

PMID:
23576709
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Targeted therapy and immunotherapy in advanced melanoma: an evolving paradigm.

Khattak M, Fisher R, Turajlic S, Larkin J.

Ther Adv Med Oncol. 2013 Mar;5(2):105-18. doi: 10.1177/1758834012466280.

PMID:
23450149
[PubMed]
Free PMC Article
11.

Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma.

Harbour JW, Roberson ED, Anbunathan H, Onken MD, Worley LA, Bowcock AM.

Nat Genet. 2013 Feb;45(2):133-5. doi: 10.1038/ng.2523. Epub 2013 Jan 13.

PMID:
23313955
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Molecular pathology of uveal melanoma.

Coupland SE, Lake SL, Zeschnigk M, Damato BE.

Eye (Lond). 2013 Feb;27(2):230-42. doi: 10.1038/eye.2012.255. Epub 2012 Dec 7. Review.

PMID:
23222563
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The pathology of ocular cancer.

Eagle RC Jr.

Eye (Lond). 2013 Feb;27(2):128-36. doi: 10.1038/eye.2012.237. Epub 2012 Nov 16. Review.

PMID:
23154492
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

High throughput mass spectrometry-based mutation profiling of primary uveal melanoma.

Daniels AB, Lee JE, MacConaill LE, Palescandolo E, Van Hummelen P, Adams SM, DeAngelis MM, Hahn WC, Gragoudas ES, Harbour JW, Garraway LA, Kim IK.

Invest Ophthalmol Vis Sci. 2012 Oct 9;53(11):6991-6. doi: 10.1167/iovs.12-10427.

PMID:
22977135
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Repression of genes involved in melanocyte differentiation in uveal melanoma.

Bergeron MA, Champagne S, Gaudreault M, Deschambeault A, Landreville S.

Mol Vis. 2012;18:1813-22. Epub 2012 Jul 4.

PMID:
22815634
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Protein kinase C inhibitor AEB071 targets ocular melanoma harboring GNAQ mutations via effects on the PKC/Erk1/2 and PKC/NF-κB pathways.

Wu X, Li J, Zhu M, Fletcher JA, Hodi FS.

Mol Cancer Ther. 2012 Sep;11(9):1905-14. doi: 10.1158/1535-7163.MCT-12-0121. Epub 2012 May 31.

PMID:
22653968
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK resistance.

Ambrosini G, Pratilas CA, Qin LX, Tadi M, Surriga O, Carvajal RD, Schwartz GK.

Clin Cancer Res. 2012 Jul 1;18(13):3552-61. doi: 10.1158/1078-0432.CCR-11-3086. Epub 2012 May 1.

PMID:
22550165
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The current state of targeted therapy in melanoma: this time it's personal.

Smalley KS, McArthur GA.

Semin Oncol. 2012 Apr;39(2):204-14. doi: 10.1053/j.seminoncol.2012.01.008. Review.

PMID:
22484192
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Metastatic uveal melanoma: biology and emerging treatments.

Woodman SE.

Cancer J. 2012 Mar-Apr;18(2):148-52. doi: 10.1097/PPO.0b013e31824bd256. Review.

PMID:
22453016
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

New strategies in melanoma: molecular testing in advanced disease.

Woodman SE, Lazar AJ, Aldape KD, Davies MA.

Clin Cancer Res. 2012 Mar 1;18(5):1195-200. doi: 10.1158/1078-0432.CCR-11-2317. Epub 2012 Jan 24. Review.

PMID:
22275506
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk